Regenerative Medicine Market Report – Research, Industry Analysis Reports and Market Demands

Global Regenerative Medicine Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Regenerative Medicine Market Report (Status and Outlook)

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Regenerative Medicine Market Size 2014-2024
- 2.1.2 Regenerative Medicine Market Size CAGR by Region
2.2 Regenerative Medicine Segment by Type
- 2.2.1 Cell Therapy
- 2.2.2 Tissue Engineering
- 2.2.3 Biomaterial
- 2.2.4 Other
2.3 Regenerative Medicine Market Size by Type
- 2.3.1 Global Regenerative Medicine Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Regenerative Medicine Market Size Growth Rate by Type (2014-2019)
2.4 Regenerative Medicine Segment by Application
- 2.4.1 Dermatology
- 2.4.2 Cardiovascular
- 2.4.3 CNS
- 2.4.4 Orthopedic
- 2.4.5 Others
2.5 Regenerative Medicine Market Size by Application
- 2.5.1 Global Regenerative Medicine Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Regenerative Medicine Market Size Growth Rate by Application (2014-2019)

3 Global Regenerative Medicine by Players

3.1 Global Regenerative Medicine Market Size Market Share by Players
- 3.1.1 Global Regenerative Medicine Market Size by Players (2017-2019)
- 3.1.2 Global Regenerative Medicine Market Size Market Share by Players (2017-2019)
3.2 Global Regenerative Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Regenerative Medicine by Regions

4.1 Regenerative Medicine Market Size by Regions
4.2 Americas Regenerative Medicine Market Size Growth
4.3 APAC Regenerative Medicine Market Size Growth
4.4 Europe Regenerative Medicine Market Size Growth
4.5 Middle East & Africa Regenerative Medicine Market Size Growth

5 Americas

5.1 Americas Regenerative Medicine Market Size by Countries
5.2 Americas Regenerative Medicine Market Size by Type
5.3 Americas Regenerative Medicine Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Regenerative Medicine Market Size by Countries
6.2 APAC Regenerative Medicine Market Size by Type
6.3 APAC Regenerative Medicine Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Regenerative Medicine by Countries
7.2 Europe Regenerative Medicine Market Size by Type
7.3 Europe Regenerative Medicine Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Regenerative Medicine by Countries
8.2 Middle East & Africa Regenerative Medicine Market Size by Type
8.3 Middle East & Africa Regenerative Medicine Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Regenerative Medicine Market Forecast

10.1 Global Regenerative Medicine Market Size Forecast (2019-2024)
10.2 Global Regenerative Medicine Forecast by Regions
- 10.2.1 Global Regenerative Medicine Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
10.7 Global Regenerative Medicine Forecast by Type
10.8 Global Regenerative Medicine Forecast by Application

11 Key Players Analysis

12 Research Findings and Conclusion

Description

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.

USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.

According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.

Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.

The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.

According to this study, over the next five years the Regenerative Medicine market will register a 23.5% CAGR in terms of revenue, the global market size will reach US$ 19000 million by 2024, from US$ 5350 million in 2019. In particular, this report presents the global revenue market share of key companies in Regenerative Medicine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Regenerative Medicine market by product type, application, key companies and key regions.

This study considers the Regenerative Medicine value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cell Therapy
Tissue Engineering
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Dermatology
Cardiovascular
CNS
Orthopedic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Regenerative Medicine market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Regenerative Medicine market by identifying its various subsegments.
Focuses on the key global Regenerative Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Regenerative Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Regenerative Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.